Best Quant-rated small- and mid-cap healthcare stocks as LLY hits $1T in market cap
As Eli Lilly (LLY) becomes the first pharmaceutical company to hit $1T in market cap, Seeking Alpha takes a look at some of...
Tag: TGTX
Roche posts late-stage trial wins for new multiple sclerosis therapy
Roche (OTCQX:RHHBY) shares closed ~4% higher in Europe on Monday as the maker of Ocrevus multiple sclerosis therapy...
TG Therapeutics raises BRIUMVI 2025 revenue guidance to $585M while advancing subcutaneous pipeline
Earnings Call Insights: TG Therapeutics (TGTX) Q3 2025 CEO Michael Weiss reported, "Our flagship product, BRIUMVI for...
TG Therapeutics EPS of $2.43, revenue of $161.71M beats by $9.54M
TG Therapeutics press release (TGTX): Q3 EPS of $2.43 may not be comparable to consensus of $0.21. Third quarter results...
TG Therapeutics announces $100M share buyback program
TG Therapeutics (NASDAQ:TGTX) announced on Wednesday that its board authorized a new share repurchase program to buy back...
TG Therapeutics files automatic mixed securities shelf
TG Therapeutics (NASDAQ:TGTX) filed automatic mixed securities shelf. Filing TG Therapeutics: Strong Execution Tempered By...
TG Therapeutics falls after Q2 miss despite guidance raise
mohd izzuanTG Therapeutics (NASDAQ:TGTX) shares lost ~18% on Monday after the Morrisville, North Carolina-based biotech fell...
TG Therapeutics raises BRIUMVI 2025 revenue guidance to $575M while advancing subcutaneous pipeline
Earnings Call Insights: TG Therapeutics (TGTX) Q2 2025 Michael S. Weiss, CEO, stated, “I'm pleased to share that we...
TG Therapeutics misses top-line and bottom-line estimates; raises FY25 outlook
TG Therapeutics press release (NASDAQ:TGTX): Q2 GAAP EPS of $0.17 misses by $0.11. Revenue of $141.15M (+92.1% Y/Y) misses...
TG Therapeutics Q2 2025 Earnings Preview
TG Therapeutics (NASDAQ:TGTX) is scheduled to announce Q2 earnings results on Monday, August 4th, before market open. The...